M Le Maréchal1, F Collange2, L Fressard2, P Peretti-Watel2, R Sebbah3, F Mikol4, E Agamaliyev4, A Gautier5, C Pulcini6, P Verger7. 1. EA4360APEMAC, université de Lorraine, université Paris-Descartes, 54000 Nancy, France. 2. UMR912 (SESSTIM), Inserm, 13000 Marseille, France; UMR_S912, IRD, Aix-Marseille université, 13000 Marseille, France; Observatoire régional de la santé Provence-Alpes-Côte d'Azur (ORS PACA), 13000 Marseille, France. 3. Union régionale des professionnels de santé - médecins libéraux (URPS-ML) PACA, 37/39, boulevard Vincent-Delpuech, 13006 Marseille, France. 4. Bureau des professions de santé, DREES, ministère des Affaires sociales, de la Santé et des Droits des femmes, 14, avenue Duquesne, 75350 Paris 07 SP, France. 5. Institut national de prévention et d'éducation pour la santé, direction des affaires scientifiques, 42, boulevard de la Libération, 93203 Saint-Denis cedex, France. 6. EA4360APEMAC, université de Lorraine, université Paris-Descartes, 54000 Nancy, France; Service de maladies infectieuses et tropicales, bâtiment des spécialités médicales, hôpitaux de Brabois, CHU de Nancy, allée du Morvan, 54511 Vandœuvre-lès-Nancy cedex, France. Electronic address: celine.pulcini@univ-lorraine.fr. 7. UMR912 (SESSTIM), Inserm, 13000 Marseille, France; UMR_S912, IRD, Aix-Marseille université, 13000 Marseille, France; Observatoire régional de la santé Provence-Alpes-Côte d'Azur (ORS PACA), 13000 Marseille, France; Inserm, F-CRIN, I-Reivac, immeuble AROPA, 35, rue Bernard-de-Ventadour, 31300 Toulouse, France.
Abstract
OBJECTIVES: France is currently facing a vaccine-hesitancy crisis. We conducted a questionnaire-based telephone interview with a large sample of general practitioners (GPs) as they play a crucial role in the vaccination process. Our main objectives were to study the GPs' vaccination behaviors when it comes to their own vaccination and that of their relatives, and the vaccine recommendations made to their patients. We also aimed to understand their opinion related to the severity of vaccine-preventable diseases and to assess their trust in various sources of information. Finally, we enquired about their opinion in terms of vaccination-related tools that could help them in their daily practice. The article aimed to present the design of this panel and survey. PATIENTS AND METHODS: Four samples of GPs (one national and three regional) were selected among all the French GPs (metropolitan France) using random sampling. Five cross-sectional surveys should be conducted with that panel. The mean targeted sample size is 2350 GPs for each survey. The survey dedicated to vaccination was conducted by telephone or on the Internet. RESULTS: GPs were included in the survey between December 2013 and February 2014. The national sample included 1582 GPs (response rate: 46%) and the three regional samples included 1297 GPs (response rate: 44%). The survey dedicated to vaccination was conducted between April and July 2014; the national sample response rate was 92% (1582/1712). CONCLUSION: The results of the first wave of surveys, conducted on a large sample of French GPs, provide important information to guide the French vaccination policy.
OBJECTIVES: France is currently facing a vaccine-hesitancy crisis. We conducted a questionnaire-based telephone interview with a large sample of general practitioners (GPs) as they play a crucial role in the vaccination process. Our main objectives were to study the GPs' vaccination behaviors when it comes to their own vaccination and that of their relatives, and the vaccine recommendations made to their patients. We also aimed to understand their opinion related to the severity of vaccine-preventable diseases and to assess their trust in various sources of information. Finally, we enquired about their opinion in terms of vaccination-related tools that could help them in their daily practice. The article aimed to present the design of this panel and survey. PATIENTS AND METHODS: Four samples of GPs (one national and three regional) were selected among all the French GPs (metropolitan France) using random sampling. Five cross-sectional surveys should be conducted with that panel. The mean targeted sample size is 2350 GPs for each survey. The survey dedicated to vaccination was conducted by telephone or on the Internet. RESULTS: GPs were included in the survey between December 2013 and February 2014. The national sample included 1582 GPs (response rate: 46%) and the three regional samples included 1297 GPs (response rate: 44%). The survey dedicated to vaccination was conducted between April and July 2014; the national sample response rate was 92% (1582/1712). CONCLUSION: The results of the first wave of surveys, conducted on a large sample of French GPs, provide important information to guide the French vaccination policy.
Authors: Hélène Carrier; Anna Zaytseva; Aurélie Bocquier; Patrick Villani; Hélène Verdoux; Martin Fortin; Pierre Verger Journal: Br J Gen Pract Date: 2019-02-25 Impact factor: 5.386